Editas Medicine Inc (EDIT): Net earnings per share for the last 12 months

EDIT (Editas Corp) - company brandmark

Editas Medicine, Inc. (EDIT) is accelerating the release of data on CRISPR/Cas12a therapy, which is confirmed by the annual EPS TTM snapshot on the GURU.Markets chart, where the value -0.62 represents the current metric. The project relies on an elite staff of geneticists and generous RSUs. Meanwhile, financial stability depends on future licenses, as the company is currently burning through capital on clinical trials.

EDIT Editas Corp Net earnings per share for the last 12 months (07/04/2022 - 11/18/2026)

Financial and market metric breakdowns for Editas (EDIT)

- current quotes and average value forecast:
Fundamental company analysis:Editas Medicine Inc (EDIT)
Manufactured products of Editas Medicine Inc

This indicator measures the actual annual return of a single stock, neutralizing short-term quarterly fluctuations and distortions caused by changes in capital structure. Analyzing the rolling 12-month EPS allows for an assessment of the financial stability of Editas Medicine, Inc. (EDIT), whose reputation as a leader in CRISPR technologies shifts the focus from current losses to the fundamental value of future breakthroughs in treating genetic pathologies.

Competitor analysis

TEM: Net earnings per share for the last 12 months|QGEN (Qiagen Group) - Earnings per share for the last 12 months|Ionis (IONS) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Repligen Inc. (RGEN)|RNA (Avidity Biosciences) - Net earnings per share (EPS TTM)|CRSP (CRISPR Therapeutics AG) - Earnings per share for the last four quarters|Earnings per share for the last twelve months GeneDx (WGS)|RARE - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) BEAM (Beam Therapeutics Inc)|Earnings per share for the trailing year SRPT|twistbioscience.com - Net earnings per share (EPS TTM)|Earnings per share for the trailing year TXG (10x Genomics, Inc.)|NTLA: Net earnings per share (EPS TTM)|Earnings per one share for the last 12 months STOK (Stoke Therapeutics, Inc.)|Net earnings per share for the last 12 months BLFS|Net earnings per one share for the last twelve months Wave Pharma WVE|Net earnings per share for the last 12 months MAZE (Maze Tx)|SION - Net earnings per one share for the last twelve months|Prime Medicine - Net earnings per share for the last 12 months|Taysha Gene Therapies Inc (TSHA) - Net earnings per one share for the last twelve months|uniqure.com - Net earnings per share (EPS TTM)|Net earnings per share for the trailing year MeiraGTx Corp (MGTX)|REGENXBIO (RGNX) - Earnings per share for the last twelve months|SLDB - Net earnings per share for the last four quarters|OCGN (ocugen.com) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Pacific Biosciences of California, Inc. PACB|Net earnings per share (EPS TTM) BNTC|Net earnings per share for the last four quarters Design Pharma|Net earnings per share (EPS TTM) RCKT (Rocket Corp)|FDMT - Net earnings per share for the last 12 months|Lexeo - Net earnings per share (EPS TTM)|KRRO - Net earnings per share (EPS TTM)|Silence Therapeutics (SLN) - Earnings per share for the last twelve months|PRQR (ProQR Therapeutics N.V.) - Earnings per share for the last twelve months|CDXS (Codexis Inc) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months sangamo.com (SGMO)|Net earnings per share (EPS TTM) NAUT|Net earnings per share (EPS TTM) Metagenomi (MGX)|Earnings per share for the last twelve months Precision BioSciences DTIL|Net earnings per share (EPS TTM) Generation Bio Corp GBIO|Boundless Bio, Inc. - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Exicure Inc.|Imunon, Inc. (IMNN) - Earnings per share for the last twelve months|RXi Pharmaceuticals (PHIO) - Net earnings per share (EPS TTM)|MBIO (Mustang Bio Corp) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months RNAZ (TransCode Therapeutics)|Net earnings per share (EPS TTM) BNGO|APDN: Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) BLUE (bluebird bio Inc.)|Net earnings per share for the last four quarters ImmunoPrecise Antibodies (IPA)|OMGA: Net earnings per share for the last 12 months|OMIC (Singular Genomics Systems Inc) - Earnings per share for the last 12 months|Regulus Therapeutics (RGLS) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months syros.com (SYRS)|TBIO (Telesis Bio Inc.) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months TRACON Pharmaceuticals Inc. (TCON)|Net earnings per share for the last 12 months UBX (Unity Biotechnology, Inc.)